The Influence of Body Size Descriptors on the Estimation of Kidney Function in Normal Weight,Overweight,Obese,and Morbidly Obese Adults

Abstract

Spanish

French

Background:

Dosing adjustments for patients with impaired kidney function are often based on estimated creatinine clearance (eCrCI) because measuring kidney (unction is not always possible for dose adjustment. However, there is no consensus on the body size descriptor that should be used in the estimation equations.

Objective:

To compare the use of alternative body size descriptors (ABSDs) on the performance of kidney function estimation equations compared with measured CrCI (mCrCI).

Methods:

We combined 2 data sources with mCrCI: a Food and Drug Administration clinical trial database that includes subjects with body mass index (BMI) less than 40 kg/m² and published data from those 40 kg/m² or more. The 3 parent equations (Cockcroft-Gault [CG], Modification of Diet in Renal Disease [MDRD], Chronic Kidney Disease-Epidemiology Collaboration [CKDEPI]), and 14 ABSD-modilied equations were compared with mCrCI for accuracy, bias, agreement, goodness of (it (R²). and prediction error. These equations were also compared across mCrCI and BMI strata.

Results:

Subjects (n = 590) were aged 19–80 years; 33.9% were female and BMI ranged from 17.2 to 95.6 kg/m². Compared with mCrCI, the use of total weight in the CG equation yielded low accuracy (12.5%) and significant bias (–107 mL/min) in the morbidly obese group. In contrast, the use of lean body weights (BMI ≥40 kg/m²) and total ± adjusted weights (BMI <40 kg/m²) with the CG equation yielded higher accuracy, greater than or equal to 60.7% across all BMI strata, and was unbiased. Transforming the MDRD or CKDEPI equations with body surface area improved accuracy only at mCrCI of 30–80 mL/min and increased the overall prediction error.

Conclusions:

No kidney function equation was consistently accurate and unbiased across weight, mCrCI. and estimate ranges. The accuracy and over-estimation bias of the CG equation in obese subjects was improved through the selective use of total, adjusted, and lean body weight by BMI strata.

Keywords

body mass index Chronic Kidney Disease Epidemiology Collaboration Cockcroft-Gault equation creatinine clearance dosing glomerular filtration rate kidney function Modification of Diet in Renal Disease obesity pharmacokinetics

Get full access to this article

View all access options for this article.

References

Ogden

, Fryar

, Carroll

, Flegal

. Mean body weight, height, and body mass index, United States, 1960–2002. Adv Data 2004; 9:1–17.

Flegal

, Carroll

, Kit

, Curtin

. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 2012; 307:491–7. DOI 10.1001/jama.2012.39

Pai

. Estimating the glomerular filtration rate in obese adult patients for drug dosing. Adv Chronic Kidney Dis 2010; 17:e53–62. DOI 10.1053/j.ackd.2010.05.010

Singer

. Of mice and men and elephants: metabolic rate sets glomerular filtration rate. Am J Kidney Dis 2001; 37:164–78. DOI 10.1016/S0272–6386(01)80073–1

Stevens

, Levey

. Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol 2009; 20:2305–13. DOI 10.1681/ASN.2009020171

Feng

, LaPerle

, Chang

, Varma

. Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state. Expert Opin Drug Metab Toxicol 2010; 6:939–52. DOI 10.1517/17425255.2010.482930

National Kidney Disease Education Program. Chronic kidney disease and drag dosing: information for providers, www.nkdep.nih.gov/professionals/drug-dosing-information.htm (accessed 2011 Jun 15).

Walser

. Assessing renal function from creatinine measurements in adults with chronic renal failure. Am J Kidney Dis 1998; 32:23–31. DOI10.1053/ajkd.1998.v32.pm9669420

Spruill

, Wade

, Cobb

3rd . Continuing the use of the Cock-croft-Gault equation for drug dosing in patients with impaired renal function. Clin Pharmacol Ther 2009; 86:468–70. DOI 10.1038/clpt.2009.187

10.

Stevens

, Levey

. Use of the MDRD study equation to estimate kidney function for drug dosing. Clin Pharmacol Ther 2009; 86:465–7. DOI 10.1038/clpt.2009.124

11.

Cockcroft

, Gault

. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31–41.

12.

Levey

, Bosch

, Lewis

. A more accurate method to estimate the glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130:461–70.

13.

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(2 suppl 1):S1–266.

14.

Levey

, Stevens

, Schmid

. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604–12.

15.

Morrish

, Pai

, Green

. The effects of obesity on drug pharmacokinetics in humans. Expert Opin Drug Metab Toxicol 2011; 7:697–706. DOI 10.2165/11318100-000000000-00000

16.

Delanaye

, Mariat

, Cavalier

, Krzesinski

. Errors induced by indexing glomerular filtration rate for body surface area: reductio ad absurdum. Nephrol Dial Transplant 2009; 24:3593–6. DOI 10.1093/ndt/gfp431

17.

Coresh

, Selvin

, Stevens

. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298:2038–47. DOI 10.1001/jama.298.17.2038

18.

Demirovic

, Pai

. Estimation of creatinine clearance in morbidly obese patients. Am J Health Syst Pharm 2009; 66:642–8. DOI 10.2146/ajhp080200

19.

Miller

, Myers

, Ashwood

. Creatinine measurement: state of the art in accuracy and interlaboratory harmonization. Arch Pathol Lab Med 2005; 129:297–304.

20.

Food and Drug Administration Guidance to Industry–Pharmacokinetics in Patients with Impaired Renal Function–Study Design, Data Analysis, and Impact on Dosing and Labeling. US Department of Health and Human Services, Food and Drug Administration, 1998. www.fda.gov/downloads/Drags/GuidanceComplianceRegulatoryInformation/Guidances/ucm072127.pdf (accessed 2012 Feb 22).

21.

Stevens

, Nolin

, Richardson

. Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis 2009; 54: 33–42. DOI 10.1053/j.ajkd.2009.03.008

22.

Dowling

, Matzke

, Murphy

, Burckart

. Evaluation of renal drug dosing: prescribing information and clinical pharmacist approaches. Pharmacotherapy 2010; 30:776–86. DOI 10.1592/phco.30.8.776

23.

The Clinician's Ultimate Reference, GlobalRPh.com, Medical Calculators, 2011. www.globalrph.com/medcalcs.htm (accessed 2011 Jun 15).

24.

Pai

, Paloucek

. The origin of the “ideal” body weight equations. Ann Pharmacother 2000; 34:1066–9. DOI 10.1345/aph.19381

25.

Bauer

, Edwards

, Dellinger

, Simonowitz

. Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients. Eur J Clin Pharmacol 1983; 24:643–7.

26.

Janmahasatian

, Duffull

, Ash

, Ward

, Byrne

, Green

. Quantification of lean bodyweight. Clin Pharmacokinet 2005; 44:1051–65.

27.

Du Bois

, Du Bois

. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17:863–71.

28.

Mosteller

. Simplified calculation of body-surface area. N Engl J Med 1987; 317:1098.

29.

Bostom

, Kronenberg

, Ritz

. Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. J Am Soc Nephrol 2002; 13:2140–4.

30.

Verhave

, Fesler

, Ribstein

, du Cailar

, Mimran

. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis 2005; 46:233–41.

31.

Cichetti

, Allison

. A new procedure for assessing reliability of scoring EEG sleep recordings. Am J EEG Technol 1971; 11:101–9.

32.

WHO. BMI classification. World Health Organization, 2011. http://apps.who.int/bmi/index.jsp?introPage=intro_3.html (accessed 2011 Jun 6).

33.

Crouter

, Churilla

, Bassett

Jr . Accuracy of the Actiheart for the assessment of energy expenditure in adults. Eur J Clin Nutr 2008; 62:704–11.

34.

Sakov

, Golani

, Lipkind

, Benjamini

. High throughput data analysis in behavioral genetics. Ann Appl Stat 2010; 4:743–63.

35.

Shemesh

, Golbetz

, Kriss

, Myers

. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985; 28:830–8.

36.

Melloni

, Peterson

, Chen

. Cockcroft-Gault versus Modification of Diet in Renal Disease–importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 2008; 10:991–6.

37.

Mahmood

. Theoretical versus empirical allometry: facts behind theories and application to pharmacokinetics. J Pharm Sci 2010; 99:2927–33. DOI 10.1002/jps.22073

38.

Janssen

, Heymsfield

, Wang

, Ross

. Skeletal muscle mass and distribution in 468 men and women aged 18–88 yr. J Appl Physiol 2000; 89:81–8.

39.

Gouin-Thibault

, Pautas

, Mahé

. Is Modification of Diet in Renal Disease formula similar to Cockcroft-Gault formula to assess renal function in elderly hospitalized patients treated with low-molecular-weight heparin? J Gerontol A Biol Sci Med Sci 2007; 62:1300–5.

40.

Denetclaw

, Oshima

, Dowling

. Dofetilide dose calculation errors in elderly associated with use of the Modification of Diet in Renal Disease equation. Ann Pharmacother 2011; 45:e44

DOI 10.1345/aph.1Q159